The Essentials of Residual Risk Video Series is offered to help address the Residual Risk of disability or death from heart disease or stroke. These cardiovascular disorders cause approximately 18 million deaths annually. After declining for nearly a half century, their frequency has been increasing over the past 5 years. Our goal is to examine the potential reasons for this increase in the major cause of death worldwide and to suggest new approaches to prevention. The IAS has developed this accredited video series to systematically address the recent information on vascular risk and to suggest new approaches to reduce this residual risk. Led by Dr William Virgil Brown, Program Director, this series brings together top experts recognized globally, regionally, and nationally to discuss real-world issues in identification of preventable risk as well as current and future treatments of risk factors.
CME credit will open on August 31, 2021 and expire on August 31, 2022.
Credit provided by AKH Inc., Advancing Knowledge in Healthcare
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and International Atherosclerosis Society (IAS). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material activity for a maximum of 7 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
7 ANCC contact hours
AAPA Credit Designation Statement
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 7 AAPA Category 1 CME credits. Approval is valid until August 31, 2022. PAs should only claim credit commensurate with the extent of their participation.
This activity is supported by educational grants from Amarin Corporation, Amryt Pharma, Novartis, Novo Nordisk, Merck & Co., and Sanofi.